Review of icatibant use in the Winnipeg Regional Health Authority

BACKGROUND: This is a retrospective review of the Winnipeg Regional Health Authority’s (WRHA) angioedema patients who were dispensed icatibant in hospital. Icatibant is a bradykinin B2 receptor antagonist indicated for Hereditary Angioedema (HAE) types I and II and is used off-label for HAE with nor...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, George, Barber, Colin, Kalicinsky, Chrystyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656671/
https://www.ncbi.nlm.nih.gov/pubmed/33292436
http://dx.doi.org/10.1186/s13223-020-00493-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656671/
https://www.ncbi.nlm.nih.gov/pubmed/33292436
http://dx.doi.org/10.1186/s13223-020-00493-3

Ejemplares similares